Has Kimberly Grant received payments from drug or device companies?

Yes. Drug and device makers reported $20,271 in general payments to Kimberly Grant across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kimberly Grant did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kimberly Grant come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kimberly Grant

Acute Care · Altamonte Springs, FLNPI 1992082150

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,450 of the $20,271 with a category attached, or 76.2%. Boehringer Ingelheim accounts for 95.6% of it on its own, with 4 other manufacturers making up the rest. Among acute care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,271in general payments, 2019–2025

Across 38 payments — averaging $533.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$19K
Inari Medical, Inc.$809
AbbVie$41
Novo Nordisk$22
Daiichi Sankyo Inc.$17

What the payments were for

Consulting fees$2,20011%
Speaking & faculty fees$15,45076%
Travel & lodging$1,3377%
Food & beverage$1,2846%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	32	$19,382
Inari Medical, Inc.	2	$809
AbbVie(2 entities)	2	$41
Novo Nordisk	1	$22
Daiichi Sankyo Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,271 in reported general payments places this provider in the 95th percentile of 1,150 acute care providers in Florida.

See all acute care providers in Florida →

Medicare billing

Part B allowed, 2024

$16,591

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Altamonte Springs

Tiffany ShearerAltamonte Springs$13K
Melisa WilsonOrlando$214K
Amanda PeacockJacksonville$81K
Katrina RileyTampa$66K
Diane GrayLake Mary$49K
Heather RamousSafety Harbor$38K
Melanie WeresJacksonville$37K
Jayne JaramilloJacksonville$27K
Melissa HamiltonTampa$23K
Julie ElliottWinter Haven$17K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →